Atlas Trials

Light Chain Deposition Disease

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Light Chain Deposition Disease

RecordFirmDate
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH (NCT05283993)Peking University First Hospital2021-07-01
Rifaximin in Patients With Monoclonal Gammopathy (NCT03820817)Emory University2019-05-15
Registry for Adults With Plasma Cell Disorders (PCD's) (NCT03717844)UNC Lineberger Comprehensive Cancer Center2018-02-09
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma (NCT01849783)Margarida Magalhaes-Silverman2013-04-04
First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD (NCT01728259)Barbara Ann Karmanos Cancer Institute2013-03-01
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01533194)National Cancer Institute (NCI)2012-04-01
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma (NCT01169337)National Cancer Institute (NCI)2011-01-24
Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis (NCT01078454)National Cancer Institute (NCI)2010-11-01
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747)National Cancer Institute (NCI)2009-08-01
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease (NCT00520767)Barbara Ann Karmanos Cancer Institute2007-09-01

Track Light Chain Deposition Disease automatically

Every clearance here is in the API, with alerts when new ones post.